» Articles » PMID: 11337943

Genetic Polymorphisms of Thiopurine S-methyltransferase and 6-mercaptopurine Toxicity in Japanese Children with Acute Lymphoblastic Leukaemia

Overview
Specialties Genetics
Pharmacology
Date 2001 May 8
PMID 11337943
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients.

Khaeso K, Nakkam N, Komwilaisak P, Wongmast P, Chainansamit S, Dornsena A J Pediatr Genet. 2021; 10(1):29-34.

PMID: 33552635 PMC: 7853920. DOI: 10.1055/s-0040-1715818.


Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia.

Zhou Y, Wang L, Zhai X, Wen L, Tang F, Yang F Br J Clin Pharmacol. 2020; 86(8):1519-1527.

PMID: 32077136 PMC: 7373713. DOI: 10.1111/bcp.14258.


Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.

Tantawy A, Ebeid F, Adly A, El-Ghoroury E, Mostafa M J Genet. 2018; 96(6):905-910.

PMID: 29321348 DOI: 10.1007/s12041-017-0853-0.


Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia.

Tanaka Y, Nakadate H, Kondoh K, Nakamura K, Koh K, Manabe A Pharmacogenomics J. 2017; 18(2):275-280.

PMID: 28418010 DOI: 10.1038/tpj.2017.12.


Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.

Mlakar V, Curtis P, Satyanarayana Uppugunduri C, Krajinovic M, Ansari M Int J Mol Sci. 2016; 17(9).

PMID: 27618021 PMC: 5037779. DOI: 10.3390/ijms17091502.